+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atovaquone"

toxoplasmosis Treatment Drugs Global Market Report 2024 - Product Thumbnail Image

toxoplasmosis Treatment Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antiparasitic Drugs Global Market Report 2024 - Product Thumbnail Image

Antiparasitic Drugs Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Atovaquone is an antibiotic used to treat a variety of infectious diseases, including malaria, toxoplasmosis, and pneumocystis pneumonia. It is a synthetic quinone compound that works by inhibiting the production of mitochondrial energy in the parasites that cause these diseases. Atovaquone is available in both oral and intravenous formulations, and is often used in combination with other drugs to increase its effectiveness. It is generally well-tolerated, with few side effects. Atovaquone is a widely used drug in the treatment of infectious diseases, and is available from a number of pharmaceutical companies. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. Other companies that produce atovaquone include Bristol-Myers Squibb, Novartis, and Teva Pharmaceuticals. Show Less Read more